Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 142.5 GBX
Market Cap: 121m GBX
Section:
 

Relative Value

The Relative Value of one DXRX stock under the Base Case scenario is hidden GBX. Compared to the current market price of 142.5 GBX, Diaceutics PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXRX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

3.5
P/S
P/S
Price to Sales
3.5
vs History
76
vs Industry
45
Median 3Y
3.7
Median 5Y
4.1
Industry
4
Forward
3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
100
Median 3Y
-42
Median 5Y
-36.1
Industry
31.9
Forward
160
More Details
1 158.6
P/OCF
P/OCF
Price to OCF
1 158.6
vs History
4
vs Industry
7
Median 3Y
63.4
Median 5Y
149
Industry
19.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-25.4
Median 5Y
-23.5
Industry
26.9
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
4
vs Industry
37
Median 3Y
2.6
Median 5Y
2.3
Industry
2.8
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
61
vs Industry
47
Median 3Y
3.2
Median 5Y
3.5
Industry
4
Forward
2.8
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
60
vs Industry
67
Median 3Y
3.7
Median 5Y
4
Industry
8.9
More Details
37
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
37
vs History
49
vs Industry
2
Median 3Y
36.3
Median 5Y
36.3
Industry
18.9
Forward
15.1
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
3
Median 3Y
-36.8
Median 5Y
-37.2
Industry
24.1
Forward
119.3
More Details
1 067.5
EV/OCF
EV/OCF
Enterprise Value to OCF
1 067.5
vs History
4
vs Industry
7
Median 3Y
53.3
Median 5Y
116.9
Industry
20.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
-21
Median 5Y
-17.8
Industry
26.9
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
30
vs Industry
29
Median 3Y
2.8
Median 5Y
3
Industry
2.3
More Details

Multiples Across Competitors

DXRX Competitors Multiples
Diaceutics PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Diaceutics PLC
LSE:DXRX
120.5m GBP 3.5 -79.3 37 -54.2
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 405.8 4 807.7 1 385 2 782.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
231.3B USD 5.3 35.3 25 32.3
US
Danaher Corp
NYSE:DHR
167.1B USD 6.9 47.6 25.5 38.6
CH
Lonza Group AG
SIX:LONN
38.3B CHF 5.4 52.2 39.7 39.7
US
IQVIA Holdings Inc
NYSE:IQV
41.7B USD 2.6 32.5 15.5 23.3
US
Agilent Technologies Inc
NYSE:A
42.1B USD 6.1 32.3 24.9 29.8
CN
WuXi AppTec Co Ltd
SSE:603259
283.4B CNY 6.4 18.9 21.5 21.5
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
30.2B USD 7.7 36.1 26 28.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
21.1B EUR 7.2 79.9 28.3 46.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Diaceutics PLC
LSE:DXRX
Average EV/EBIT: 306.5
Negative Multiple: -54.2 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
2 782.4
29%
95.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
32.3
15%
2.2
US
Danaher Corp
NYSE:DHR
38.6
16%
2.4
CH
Lonza Group AG
SIX:LONN
39.7
22%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
23.3
15%
1.6
US
Agilent Technologies Inc
NYSE:A
29.8
23%
1.3
CN
WuXi AppTec Co Ltd
SSE:603259
21.5
23%
0.9
KR
Samsung Biologics Co Ltd
KRX:207940
22.5
28%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
28.9
5%
5.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
46.6
31%
1.5

See Also

Summary
DXRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXRX stock valuation using valuation multiples.
Wall Street Estimates
DXRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.